Condition: Breast Cancer · Sponsor: Fudan University
The study was designed to investigate whether hypofractionated radiotherapy(HF-RT) is noninferior to conventionally fractionated radiotherapy (CF-RT) in terms of tumor loco-regional control for patients after breast conserving surgery
This description comes directly from the study's public registry record.
Xiaoli Yu, MD, PhD · +86-13817893133 · stephanieyxl@hotmail.com
Jurui Luo, PhD · +86-13162996951 · juruiluo@hotmail.com
Always discuss trial participation with your own doctor first.
| Guizhou Provincial People's Hospital | Guiyang, Guizhou, China | Not Yet Recruiting |
| Suzhou Municipal hospital | Suzhou, Jiangsu, China | Recruiting |
| The Second Hospital of Dalian Medical University | Dalian, Liaoning, China | Not Yet Recruiting |
| Shanghai Huangpu District Central Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Fudan University Shanghai Cancer Center | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04025164